Neutrophils have key roles in modulating the immune response. We present a robust methodology for rapidly isolating neutrophils directly from whole blood with 'on-chip' processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and by comparison with standard bulk isolation methodologies. Last, we implement this tool as part of a near-patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury. The preliminary results from a small cohort of subjects in our study and healthy controls show a unique time-dependent gene expression pattern clearly demonstrating the ability of this tool to discriminate temporal transcriptional events of neutrophils within a clinical setting.
Neutrophils, which are the most common type of blood leukocyte, are crucial for protection against infections and modulation of inflammatory responses 1 . Although neutrophils were once thought of as terminally differentiated cells with few roles outside of phagocytosis and granule content release, it is clear from the literature that protein synthesis and gene regulation play a major part in neutrophil function and innate immune signaling 2, 3 . Furthermore, it is well recognized that neutrophils contribute to both chronic and acute inflammation and are a key part of a complex temporal pattern of activation of the immune system after injury. As such, an expanded role for neutrophils in adaptive immunity is now being suggested 1 .
In a clinical setting, the peripheral blood is an easily accessible tissue, and there is great interest in using leukocyte transcript profiling to understand disease processes 4, 5 . It was recently shown that differential genomic changes can be observed in distinct blood leukocyte subpopulations in response to the same in vivo stimulus 6 . However, the genomic changes seen in the total leukocyte population were blunted in comparison to individual cell types, as would be expected.
This observation has led to the practice of enriching leukocytes into more homogeneous subpopulations to allow for clearer functional interpretation of gene expression patterns 6 . Unfortunately, the fractionation of leukocytes into several subpopulations is technically challenging and extremely time consuming.
To date, the investigation of neutrophils by genomic and proteomic technologies has been hampered by three major challenges. First, standard methods for neutrophil isolation require multistep density gradient separation, which involves several hours (>2) of processing time and uses milliliter volumes of blood (typically 4-8 ml) 7 . Second, neutrophils are especially sensitive to external perturbations and can be easily activated during the isolation process 8 . Third, neutrophils contain 10-20 times less mRNA per cell than monocytes 9 , thus requiring increased cell numbers for an equivalent quantity of nucleic acids. We thus sought to develop a cost-effective, easy method to isolate a highly enriched population of neutrophils from whole blood that can be readily used in a clinical setting.
We have previously created microfluidic tools that use affinity capture to isolate cellular subpopulations directly from whole blood in people with HIV 10 or metastatic cancer 11 . Although these studies demonstrated the potential for microfluidic sample processing within a specialized laboratory setting, the tools have not been applied in a multicenter clinical program, owing to the high technical skills required to use the microfluidic devices. Additionally, molecular analysis of the captured cell populations in these studies has been limited to a narrow set of known candidate genes as a result of the lack of cell purity, and the sensitivity for proteomics analysis has been challenging because of the low total protein content available. As a result, microfluidic blood processing tools have not yet been combined with the types of genome-wide microarray or proteomic analyses that would be fundamental to identifying biomarkers and understanding the biological basis of disease at a molecular level.
Clinical microfluidics for neutrophil genomics and proteomics
Here we report a microfluidic tool that in 5 min captures highly enriched (>95%) neutrophils directly from 150 μl of whole blood in sufficient quantity and purity for genome-wide microarray and massspectrometry-based proteomic analysis. We show that the genomic and proteomic samples resulting from microfluidic cell isolation are of sufficiently high quality to discriminate between subtle differences in neutrophil activation states. Moreover, we implemented the use of this microfluidic neutrophil-capture cassette by nonspecialized staff in a multicenter clinical program and observed gene expression changes in neutrophils that are highly regulated after trauma injury. We anticipate that this device will have a wide range of applications for furthering the biological and therapeutic investigations of neutrophils and that this approach will be transferrable to other cell types in the peripheral blood.
RESULTS

Characterization of cell capture
We designed a device that could capture neutrophils directly from 150 μl of whole blood. We chose a CD66b-specific antibody as the capture antibody, which captures all polymorphonuclear leukocytes bearing carcinoembryonic antigen-related cell adhesion molecule-8, an adhesion molecule expressed on neutrophils and eosinophils. Neutrophils typically outnumber eosinophils by a factor of 30, and we deemed a potential eosinophil contamination of ~3% acceptable for the studies described below. We determined the optimal shear stress of 0.45 dyn cm −2 for capturing neutrophils at a high density on the device surface, and we chose a chamber height of 50 μm on the basis of previous studies 10 . We then determined the surface area of the chambers that would capture sufficient numbers of cells for carrying out downstream genomic and proteomic studies. We finalized the design (Fig. 1a,b ) that maximizes the width of a device on a 38 mm × 75 mm microscope slide. The final device consists of discrete chambers that divide the flow to obtain a more uniform flow distribution across the width of the device. At an optimal flow rate of 30 μl min −1 , the number of neutrophils captured by the device is proportional to the starting volume of whole blood over a range of 10-250 μl ( Fig. 1c,d) , with a captured neutrophil purity of >96%, as evaluated by on-device Wright-Giemsa and immunofluorescent staining (Fig. 1e,f and Table 1 ; phenotyping of the remaining 4% population is given in Supplementary Table 1 ). To test the effects of severe inflammation on the ability to capture cells, we examined samples from five severely burned individuals and found no change in the obtained cell purity ( Table 1 and Supplementary Table 1 ).
RNA and protein extraction
For genomic analyses, we lysed captured cells in situ on the device with guanadinium-based chaotropes, extracted total RNA and analyzed it for nucleic acid quantity and quality. The amount of total RNA recovered was linear over the range of capture ( Fig. 1d) , RNA quantity (0.33 ± 0.15 pg cell −1 ) was similar to other studies 12 and RNA quality as measured on an Agilent Bioanalyzer 2100 was excellent, with a RNA integrity number range of 7.4-9.9 ( Table 1 and Supplementary  Fig. 1 ) 13 . The correlations of mRNA abundance between multiple samples isolated by the microfluidic cassettes were 0.98 ± 0.02 (n = 12), demonstrating the high reproducibility of the sampling. Table 7 ). For mass spectrometry-based proteomic analysis, we optimized the reagent and lysis conditions (Supplementary Table 2 ) to maximize the number of peptides and proteins identified for samples with low total protein content. We observed that the chips can consistently capture ~4 × 10 5 neutrophils, which is sufficient for proteomic analysis with an average of ~2,430 peptides and ~860 proteins identified per chip with a single reverse-phase liquid chromatography separation coupled with mass spectrometry (LC-MS) ( Table 1) . Notably, chip-to-chip correlations based on peptide intensities were extremely high (0.96 ± 0.02) for replicate samples. Protein distribution based on cellular components was nearly identical to Ficoll-dextran-isolated neutrophils, suggesting that there was no differential adsorption of cellular proteins to the surface of the device (Supplementary Fig. 2) .
Ex vivo stimulation studies
We next assessed whether the relatively small number of isolated neutrophils captured by the microfluidics cassettes would permit the potential discriminatory capabilities of genomic and proteomic analyses in response to various stimuli. We compared the genomewide expression profile and protein abundance profile in neutrophils after ex vivo activation with either Escherichia coli lipopolysaccharide (LPS) or lymphokine stimulation with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interferon-γ (IFN-γ). In both protocols, we stimulated whole blood ex vivo to allow leukocyte and plasma protein interactions 14 . To limit the effects of intersubject biological variability, we performed multiple cassette isolations from a single biological sample for each experiment arm. Neither capture purity nor cell viability (assessed by trypan blue exclusion) of the isolated cells was affected by the stimulation ( Table 1) .
Unsupervised hierarchical clustering of the genomic and proteomic data from the cassette extractions showed patterns of neutrophil RNA expression and protein abundance distinct among the two stimulation protocols and from unstimulated neutrophils ( Fig. 2) . Samples clustered according to stimulation condition, thus verifying the ability of the cassette to isolate cells with varying activation states and subsequently resolve details of the distinct activation pathways. Correlations between multiple extractions within a single sample were excellent for both the genomic data (0.98 ± 0.02) and the proteomics data (0.96 ± 0.02), indicating a high level of sampling reproducibility. Overall, 12-14% of the approximately 21,000 genes measured on the microarray were significantly perturbed (fold changes >2 and false discovery rate (FDR) < 0.01) after either stimulation (LPS or GM-CSF plus IFN-γ), and 12-15% among the 600 consistently detectable proteins were also changed (fold changes >2 and FDR < 0.05) (Supplementary Table 3) . Sixty-two percent of the significant genes overlapped between LPS and GM-CSF plus IFN-γ ( Fig. 2c) ; among these, most genes (1,684 of 1,690) showed the same trend of changes after either stimulation. Similarly, 45% of the significant proteins overlapped, and all showed the same trend of changes between the two stimulations ( Fig. 2d) . In addition, we examined a number of the gene products found in the microarray studies by flow cytometry. Although neutrophils are traditionally considered phagocytic cells, recent studies have shown their capability for presenting antigens with human leukocyte antigen-DR (HLA-DR) and chemokine signaling with CCL20, associated with activation and migration of regulatory T cells and T helper type 17 lymphocytes [15] [16] [17] . CCL20 was upregulated in the LPS-stimulated sample compared to the GM-CSF plus IFN-γ sample, whereas HLA-DR showed the opposite trend ( Fig. 2e) . These results examining surface proteins are consistent with the microarray results, confirming that the changes in HLA-DR and CCL20 are probably not due to an artifact or a contaminating cell population.
We next examined the metabolic and cell signaling pathways from the gene expression and protein identification data in Figure 2 with the Ingenuity Pathway Analysis system 5 . A complete list of the statistically significant (P < 0.05) functional pathways identified is provided in Supplementary Table 4 . Cytokine signaling pathways were upregulated in the stimulated samples as compared to the unstimulated samples ( Fig. 2 and Supplementary Table 4) . Also, antigen presentation was significantly upregulated for the GM-CSF plus IFN-γ stimulation when compared to both unstimulated and LPS-stimulated samples ( Fig. 2 and Supplementary Table 4) . Thus, microfluidic cassette-isolated neutrophils yield genomic data that can be discriminated at the functional level as well as the gene level. 
Intersubject reproducibility
To further ensure the reliability of the microfluidic method, we performed parallel neutrophil isolations using both microfluidics and Ficoll-dextran methodologies from five healthy volunteers and processed the cell lysates for microarray analysis. Correlations of the microarray data between subjects were 0.95 ± 0.01 and 0.96 ± 0.01 for the microfluidic samples and Ficoll-dextran isolations, respectively, and are consistent with subject-to-subject gene expression variability seen in total leukocyte preparations 18 . To test possible differences at the gene level, we first performed unsupervised hierarchical clustering of the expression data. The microfluidic-isolated and Ficoll-dextranisolated neutrophils did not show any distinct clustering according to the method of neutrophil isolation ( Fig. 2f and Supplementary Table 5 ). Furthermore, no probe sets were identified as significantly different in expression between the two isolation methods at FDR < 0.05, suggesting that the variance due to baseline gene expression and sample processing is on the order of or larger than the differences between isolation methodologies. Although the number of probe sets (957) where the average expression differs by more than twofold between microfluidic and Ficoll-dextran isolation may suggest a difference between the two isolation methods, we cannot observe these probe sets with statistical certainty even at a FDR of <0.25 ( Supplementary  Table 6 ). Furthermore, it should be noted that the differences between isolation methodologies are small compared to changes caused by activation, in which case >3,700 genes change after activation by either LPS or GM-CSF plus IFN-γ at a FDR of <0.01 and a fold change >2.
Clinical implementation
To demonstrate the utility of this technology in the clinical setting, we implemented microfluidic neutrophil isolation and processing methods in the genomic sampling arm of a multicenter study looking at genomic changes after severe trauma (Fig. 3) . After providing hands-on training, we supplied preassembled microfluidic devices as part of single-use kits to clinical staff or research technicians at six clinical sites, listed in Supplementary Table 7 . Using the deviceloading data (Fig. 1) and complete blood counts from severely burned and trauma subjects, we calculated the blood requirements (150 μl) needed to yield >20 ng of total cellular RNA in 99% of the clinical samples, a quantity of RNA that is more than sufficient to achieve reliable amplification for microarray expression studies using currently available amplification systems 19 . To reduce the biological effects of sample processing, we developed a 20-min protocol for RNA is scored on a scale of one to ten (higher is better), and any sample that scored four or higher was processed for microarray expression analysis. (c) Correlation of the total extracted RNA with clinical polymorphonuclear leukocyte counts taken from a complete blood count with five-part differential; the solid line is a linear fit (R = 0.23) through the origin with 95% confidence limits (dashed line) and 95% prediction bands (dotted line). (d) Syringe pump unit used at the clinical sites for sample processing. Figure 4 Summary of the microarray results for a subset of the clinical samples from Figure 3 . For the preliminary analysis shown here, we chose transcripts with a statistical significance of ≤ 0.001 (Q value), corresponding to 8,719 genes. (a) Unsupervised K-means clustering of these 8,719 genes identified from the 187 microarrays in the time-course clinical data, leading to five distinct clusters (from top to bottom): 1, early upregulation with resolution; 2, late upregulation with a peak signal at 7-21 d; 3, early downregulation with resolution at 14-21 d; 4, early downregulation without recovery; and 5, late downregulation without recovery. (b) Bar graph of the ten most statistically significant (all P < 0.05) upregulated pathways (red) and downregulated pathways from the genes in a.
obtaining the neutrophil cell lysate from whole blood 20 . This processing time is shorter than the 30-min transcriptional time lag seen in vitro after Toll-like receptor activation with LPS 21 and in vivo with LPS-stimulated volunteers in whom gene expression showed marked differences within a 2-h period 5 . We provided over 1,000 cassettes to process blood from severely burned or trauma subjects. The total RNA extracted from the samples processed at the clinical sites met targets in quantity and quality in 98% of the samples (Fig. 3a,b) . Total RNA extraction quantities correlated in a linear fashion with clinical neutrophil counts on the basis of the subjects' complete blood count (Fig. 3c) . Additionally, there were no significant effects in the quantity and quality of the data based on cassette production batches (Supplementary Fig. 3) .
Because the RNA met internal standards for quantity and quality, 187 samples were processed for microarray analysis. In Figure 4 we present the results from 26 trauma subjects at seven time points over the first 28 d after injury. Control data were derived from ten healthy normal subjects and used as a baseline for data clustering. Notably, the expression level of 25% of the genes (7,818 of 34,834) was significantly changed over the time course at an FDR adjusted probability level of <0.001 ( Supplementary Table 8 ). An unsupervised hierarchical clustering shows five distinct groups, including genes that showed early upregulation in the first day and resolution to baseline around day 14, genes that showed delayed upregulation 4-7 d after trauma, with peak expression between 7 and 21 d, genes that were downregulated early in day 1 and resolved by day 21 (mirror of the first group), genes that were initially downregulated and remained so throughout the sampling period (28 d) and genes that were downregulated after day 4 without recovery to baseline. A complete list of the statistically significant functional pathways identified from these genes is provided in Supplementary Table 9 . These data indicate that we are able to discern complex transcriptional regulation patterns that occur over a 28-d period after injury. This uniform performance shows the potential of our device for on-site and near-site clinical sample genomics.
DISCUSSION
To date, several key genomic and proteomic studies have focused on aspects of neutrophil biology, such as development 22 , apoptosis 23 and response to pathogens 24, 25 . Of these basic studies, our ex vivo stimulation data compare well with previous microarray data looking at LPS stimulation of enriched neutrophils [24] [25] [26] . In our ex vivo study, we identify all of the genes observed in two previous studies 24, 25 , with 87% showing the same relative change in expression. We see 78% of the genes identified in another study 26 , with 84% of the genes changing in the same direction. Another microarray study examined the response of purified neutrophils to GM-CSF at 18 h 27 ; our GM-CSF plus IFN-γ data identify 99.9% of the gene transcripts in this study, with 65% of the genes showing the same trend in relative gene expression. These are noteworthy observations, given that we are using different microarray platforms, different experimental conditions and different cell numbers. Thus, these observations verify that the expression changes that we observe are originating from neutrophil signals, and cross-signals from possible contaminants are generally small if not absent 16 . Furthermore, we observed no statistically significant differences when comparing the gene expression of neutrophils derived from various isolation methodologies, suggesting that minimal bias is introduced with the microfluidic isolation method. We can, however, measure large, statistically significant gene responses between model adaptive and innate stimuli in a small population of cells, which is crucial for downstream '-omics' analyses.
To our knowledge, the genomic data from neutrophils isolated from trauma subjects using the microfluidic device described in this paper represents the single largest microarray study of neutrophils published to date, both in terms of number of subjects (26 subjects, 10 controls) and number of microarrays (187). Pathway analysis shows that there is a general increase in metabolic pathways for this patient subset, whereas there is a general downregulation of cell-death and chemokine signaling pathways (Fig. 4b) . Current analysis is ongoing to determine the biological importance of these results and the correlation of gene expression with clinical trajectories over time.
Although microarray technology for gene expression is well established, mass spectrometry-based proteomics is being rapidly developed to quantitatively examine a large number of proteins in cells 28 , providing key information on post-transcriptional and posttranslational regulation of cells 29 . In our ex vivo stimulation experiment, we observed a strong concordance between gene expression and protein abundance changes for the 15 proteins that were significantly changed and were known to interact with LPS, as identified through the Ingenuity Pathway Analysis system. Among these 15 genes, 12 genes showed the same direction of changes between mRNA and protein abundances ( Supplementary Table 10 ). This observation is consistent with a recent report that mRNA and protein data often agree well on specific biological pathways 29 . In contrast, we examined all the gene expression profiles for a set of proteins substantially perturbed by LPS to identify changes of opposite directions at the gene versus protein levels (Supplementary Table 11) . Several examples are provided. After stimulation, nucleolin, a protein involved in the synthesis and maturation of ribosomes, is 2.4-fold increased at the mRNA level but is 1/29th of the original protein level, which corresponds to a trend observed previously 30 , suggesting a selective degradation of this protein after LPS stimulation. In addition, the endogenous amount of lipocalin-2, a secretive protein crucial to antibacterial innate immune response 31 and known to be induced by LPS 32 , was decreased by one third, despite a sixfold increase of mRNA. The integrative analysis of genes and proteins of neutrophils isolated from subject samples with this microfluidics device is likely to provide unique insights into the regulation of protein expression in the clinical setting.
In this article, we described the design and application of a new microfluidic device that rapidly and reproducibly separates neutrophils from whole blood for both microarray-and mass spectrometry-based proteomic analyses. We demonstrated the scalability of the device, its applicability in a clinical setting and its versatility in processing samples for multiple downstream analyses. This neutrophil separation device should be useful for monitoring diseases that are in some part characterized by inflammation and will enable the study of new patient populations where blood sampling volumes are limited (for example, neonates and small children). With minor modifications, this device can also be used to isolate other cell subpopulations, as well as to capture cells from other clinical samples, such as bronchoalveolar lavage, urine and cerebrospinal fluid. As a result, this device should open up new applications of clinical genomics to disease and therapeutic monitoring.
METhODS
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